| 9.00 Delayed Data As of Feb 22 |  +0.30 / +3.45%Today’s Change | 4.53 Today|||52-Week Range 9.95 | +11.52% Year-to-Date |
| Previous close | 8.70 |
| Today’s open | 8.69 |
| Day’s range | 8.67 - 9.00 |
| Volume | 516,856 |
| Average volume (3 months) | 670,048 |
| Market cap | $985.7M |
| Earnings growth (last year) | +5,208.43% |
| Earnings growth (this year) | -25.78% |
| Earnings growth (next 5 years) | +19.86% |
| Revenue growth (last year) | -4.43% |
| P/E ratio | NM |
| Price/Sales | 16.46 |
| Price/Book | 10.56 |
| Today’s change | Today’s % change | |
|---|---|---|
| IFRXInflarx NV | 0.00 | 0.00% |
| NTLAIntellia Therapeutic... | 0.00 | 0.00% |
| CHRSCoherus BioSciences ... | 0.00 | 0.00% |
| DCPHDeciphera Pharmaceut... | 0.00 | 0.00% |
| Next reporting date | March 4, 2019 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $25.2M |
| Annual profit (last year) | -$65.8M |
| Net profit margin | -261.18% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Jon P. Stonehouse |
Vice President-Investor Relations & Operations Robert Bennett |
Corporate headquarters Durham, North Carolina |
